Early fetal growth, PAPP-A and free β-hCG in relation to risk of delivering a small-for-gestational age infant

Ultrasound in Obstetrics and Gynecology

Volumn 37, Issue 3, 2011, Pages 341-347

  Kirkegaard, I ^a   Henriksen, T B ^a   Uldbjerg, N ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

BPD; CRL; Early fetal growth; FGR; Free human chorionic gonadotropin; IUGR; Low birth weight; Pregnancy associated plasma protein A; SGA

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BLOOD; DENMARK; ECHOGRAPHY; FEMALE; FETUS DEVELOPMENT; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; METABOLISM; NEWBORN; PREGNANCY; RISK FACTOR; SMALL FOR DATE INFANT;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DENMARK; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 79951933270     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.8808     Document Type: Article

References (28)

1. Kady M, Gardosi J. Perinatal mortality and fetal growth restriction. Best Pract Res Clin Obstet Gynaecol 2004; 18: 397-410. (Pubitemid 38950047)
2. Lindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005; 25: 258-264.
3. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR,Wolfe HM, Vidaver J, D'Alton ME. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004; 191: 1446-1451. (Pubitemid 39421612)
4. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R, First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004; 191: 1452-1458. (Pubitemid 39421613)
5. Spencer K, Cowans NJ, Avgidou K, Molina F, Nicolaides KH. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 2008; 31: 15-19. (Pubitemid 351211925)
6. Kallen K. Increased risk of perinatal/neonatal death in infants who were smaller than expected at ultrasound fetometry in early pregnancy. Ultrasound Obstet Gynecol 2004; 24: 30-34. (Pubitemid 38932244)
7. Nakling J, Backe B. Adverse obstetric outcome in fetuses that are smaller than expected at second trimester routine ultrasound examination. Acta Obstet Gynecol Scand 2002; 81: 846-851. (Pubitemid 35026061)
8. Smith GC, Smith MF, McNay MB, Fleming JE. First-trimester growth and the risk of low birth weight. N Engl J Med 1998; 339: 1817-1822. (Pubitemid 29005786)
9. Bukowski R, Smith GC, Malone FD, Ball RH, Nyberg DA, Comstock CH, Hankins GD, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, FASTER Research Consortium. Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study. BMJ 2007; 334: 836.
10. Fox NS, Shalom D, Chasen ST. Second-trimester fetal growth as a predictor of poor obstetric and neonatal outcome in patients with low first-trimester serum pregnancy-associated plasma protein-A and a euploid fetus. Ultrasound Obstet Gynecol 2009; 33: 34-38.
11. Pedersen NG, Wojdemann KR, Scheike T, Tabor A. Fetal growth between the first and second trimesters and the risk of adverse pregnancy outcome. Ultrasound Obstet Gynecol 2008; 32: 147-154.
12. Leung TY, Sahota DS, Chan LW, Law LW, Fung TY, Leung TN, Lau TK. Prediction of birth weight by fetal crown - rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester. Ultrasound Obstet Gynecol 2008; 31: 10-14. (Pubitemid 351211924)
13. Kirkegaard I, Petersen OB, Uldbjerg N, Torring N. Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. Prenat Diagn 2008; 28: 839-844.
14. Robinson HP, Fleming JE. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
15. Altman DG, Chitty LS. New charts for ultrasound dating of pregnancy. Ultrasound Obstet Gynecol 1997; 10: 174-191. (Pubitemid 27472452)
16. Henriksen TB, Hedegaard M, Secher NJ, Wilcox AJ. Standing at work and preterm delivery. Br J Obstet Gynaecol 1995; 102: 198-206.
17. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85: 843-848. (Pubitemid 26267023)
18. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000; 107: 1265-1270.
19. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD,Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87: 1762-1767. (Pubitemid 34615266)
20. Smith GC, Shah I, Crossley JA, Aitken DA, Pell JP, Nelson SM. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 2006; 107: 161-166.
21. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002; 22: 778-782.
22. Cole LA, Kohorn EI, Kim GS. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels. J Reprod Med 1994; 39: 193-200. (Pubitemid 24103586)
23. Chervenak FA, Skupski DW, Romero R, Myers MK, Smith- Levitin M, Rosenwaks Z, Thaler HT. How accurate is fetal biometry in the assessment of fetal age? Am J Obstet Gynecol 1998; 178: 678-687.
24. Smith GC. First trimester origins of fetal growth impairment. Semin Perinatol 2004; 28: 41-50. (Pubitemid 38298828)
25. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 2005; 25: 949-953. (Pubitemid 41494994)
26. Dane B, Dane C, Kiray M, Cetin A, Koldas M, Erginbas M. Correlation between first-trimester maternal serum markers, second-trimester uterine artery doppler indices and pregnancy outcome. Gynecol Obstet Invest 2010; 70: 126-131.
27. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 2008; 28: 1110-1115.
28. Law LW, Leung TY, Sahota DS, Chan LW, Fung TY, Lau TK. Which ultrasound or biochemical markers are independent predictors of small-for-gestational age? Ultrasound Obstet Gynecol 2009; 34: 283-287.